Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Discovery could lead to improved stem cell therapy
Whilst the human endometrium is known to harbour stem cells, this is the first time they have been obtained from the equine uterus.
Stem cells harvested from equine uterus for the first time

A new discovery could reduce pain and stress in horses undergoing stem cell therapy, according to a team of scientists who managed to harvest stem cells from the equine uterus for the first time.

Stem cells are used therapeutically in horses with tendon and joint injuries, but they are usually obtained surgically from bone marrow or fat tissue. However, stem cells can be taken from the uterus, without the need for surgical intervention, using small instruments inserted via the cervix.

Scientists from Vetmeduni Vienna collected uterine tissue samples from six mares. Suspected stem cells were separated from the endometrial epithelial cells and expanded in cell culture. Various molecular biology techniques were then used to identify potential stem cells.

The cells clearly expressed the same markers as bone marrow stem cells, according to the research team. They were also able to show that the endometrial stem cells differentiated into fat, bone, cartilage and muscle cell lines.

Whilst the human endometrium is known to harbour stem cells, this is the first time they have been obtained from the equine uterus.

“The endometrium provides a source of mesenchymal stem cells that can be easily accessed with little stress to the animals,” said senior researcher Christine Aurich.

“The cell culture results show that these cells can be of benefit not only in the treatment of uterine conditions, but that they can also replace the need for surgically obtained stem cells for therapeutic purposes in other tissue types.”

The full results have been published in the journal Stem Cell Research and Therapy.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.